6
Clinical Trials associated with VGR-R01 / Not yet recruitingPhase 3 A Multi-Center, Randomized, Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of VGR-R01 in Subjects with Bietti Crystalline Dystrophy
This is a phase 3 study to evaluate the efficacy and safety of VGR-R01 in subjects with Bietti Crystalline Dystrophy.
This is a multicenter, randomized controlled study which will enroll 45 subjects.
VGR-R01 治疗结晶样视网膜变性(BCD)的 I 期临床研究
[Translation] Phase I clinical study of VGR-R01 for the treatment of BCD
主要目的:评估 VGR-R01治疗结晶样视网膜变性(BCD)的安全性和耐受性。 次要目的: 1) 探索 VGR-R01治疗BCD的有效性; 2) 评估 VGR-R01的免疫原性; 3) 评估 VGR-R01的载体脱落情况。
[Translation] Primary objective: To evaluate the safety and tolerability of VGR-R01 in the treatment of BCD. Secondary objectives: 1) To explore the efficacy of VGR-R01 in the treatment of BCD; 2) To evaluate the immunogenicity of VGR-R01; 3) To evaluate the vector shedding of VGR-R01.
/ Not yet recruitingPhase 1 A Phase 1 Study to Assess the Safety and Tolerability of VGR-R01 in Patients With Bietti Crystalline Dystrophy
A Multicenter, Open-Label, Non-Randomized, Uncontrolled Study of VGR-R01 in Patients with Bietti Crystalline Dystrophy.
100 Clinical Results associated with VGR-R01
100 Translational Medicine associated with VGR-R01
100 Patents (Medical) associated with VGR-R01
100 Deals associated with VGR-R01